Corcept Therapeutics Incorporated (CORT)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 675,040 | 628,555 | 569,610 | 523,529 | 482,375 | 450,026 | 428,153 | 413,824 | 401,858 | 397,624 | 392,027 | 380,229 | 365,978 | 352,891 | 343,087 | 340,064 | 353,874 | 356,034 | 351,212 | 334,904 |
Property, plant and equipment | US$ in thousands | — | — | — | — | — | 480 | 413 | 461 | 1,776 | 801 | 2,264 | 726 | 1,002 | 1,226 | 2,938 | 1,481 | 1,675 | 1,311 | 619 | 880 |
Fixed asset turnover | — | — | — | — | — | 937.55 | 1,036.69 | 897.67 | 226.27 | 496.41 | 173.16 | 523.73 | 365.25 | 287.84 | 116.78 | 229.62 | 211.27 | 271.57 | 567.39 | 380.57 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $675,040K ÷ $—K
= —
Corcept Therapeutics Incorporated's fixed asset turnover ratio has fluctuated over the period from March 31, 2020, to December 31, 2024. The fixed asset turnover ratio measures a company's ability to generate sales from its investment in fixed assets, such as property, plant, and equipment.
From the data provided, we observe that the fixed asset turnover ratio has shown significant variability. The ratio reached its highest point of 1,036.69 on June 30, 2023, indicating that the company generated $1,036.69 in sales for each dollar invested in fixed assets at that time.
Conversely, the ratio dipped to its lowest point of 116.78 on June 30, 2021, suggesting a significant decrease in sales generated per dollar invested in fixed assets during that period.
Overall, it is important to note that while a higher fixed asset turnover ratio generally indicates better efficiency in asset utilization, the fluctuations observed in Corcept Therapeutics Incorporated's ratio may be due to a variety of factors such as changes in sales volume, asset management strategies, or capital expenditure decisions. It would be beneficial to further investigate the underlying reasons for these fluctuations in order to gain a better understanding of the company's operational performance and efficiency in utilizing its fixed assets.
Peer comparison
Dec 31, 2024